1. Discovery of I-0436650, a potent and selective SHP2 allosteric inhibitor for the treatment of RAS driven solid tumors. (October 2022) Authors: Puca, F.; Fodale, V.; Randazzo, P.; Fabbrini, D.; Missineo, A.; Bisbocci, M.; Esposito, S.; Nibbio, M.; Amaudrut, J.; Colaceci, F.; Sasso, R.; Scalabrì, F.; Loponte, S.; Alli, C.; Pucci, V.; Montalbetti, C.; Di Fabio, R.; Petrocchi, A.; Carugo, A.; Toniatti, C. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗